JPWO2023178339A5 - - Google Patents
Info
- Publication number
- JPWO2023178339A5 JPWO2023178339A5 JP2024555341A JP2024555341A JPWO2023178339A5 JP WO2023178339 A5 JPWO2023178339 A5 JP WO2023178339A5 JP 2024555341 A JP2024555341 A JP 2024555341A JP 2024555341 A JP2024555341 A JP 2024555341A JP WO2023178339 A5 JPWO2023178339 A5 JP WO2023178339A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- promoter
- expression
- raav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263321264P | 2022-03-18 | 2022-03-18 | |
| US63/321,264 | 2022-03-18 | ||
| PCT/US2023/064673 WO2023178339A2 (en) | 2022-03-18 | 2023-03-18 | Methods and compositions for treating tnnt2 related cardiomyopathy with a viral vector |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025509828A JP2025509828A (ja) | 2025-04-11 |
| JPWO2023178339A5 true JPWO2023178339A5 (https=) | 2026-03-27 |
| JP2025509828A5 JP2025509828A5 (https=) | 2026-03-27 |
Family
ID=88024553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024555341A Pending JP2025509828A (ja) | 2022-03-18 | 2023-03-18 | ウイルスベクターによるｔｎｎｔ２関連心筋症を処置するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250195694A1 (https=) |
| EP (1) | EP4493702A4 (https=) |
| JP (1) | JP2025509828A (https=) |
| KR (1) | KR20250007509A (https=) |
| AU (1) | AU2023234604A1 (https=) |
| CA (1) | CA3254775A1 (https=) |
| IL (1) | IL315697A (https=) |
| WO (1) | WO2023178339A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025214477A1 (en) * | 2024-04-12 | 2025-10-16 | Skyline Therapeutics (Shanghai) Co., Ltd. | Treatment of genetic cardiomyopathies with aav gene therapy vectors |
| WO2025226841A1 (en) * | 2024-04-24 | 2025-10-30 | Kate Therapeutics, Inc. | Gene therapy approach for treating disorders associated with tnnt2 |
| WO2025235807A1 (en) * | 2024-05-10 | 2025-11-13 | Solid Biosciences, Inc. | Compositions and methods to improve graft survival |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5553547B2 (ja) * | 2009-07-14 | 2014-07-16 | 俊一 梶岡 | トロポニン含有医薬組成物 |
| US9783805B2 (en) * | 2013-02-28 | 2017-10-10 | City Of Hope | Replication capable rAAV vectors encoding inhibitory siRNA and methods of their use |
| EP2792742A1 (en) * | 2013-04-17 | 2014-10-22 | Universitätsklinikum Hamburg-Eppendorf (UKE) | Gene-therapy vectors for treating cardiomyopathy |
| AU2019258830B2 (en) * | 2018-04-27 | 2025-12-18 | Universität Heidelberg | Modified AAV capsid polypeptides for treatment of muscular diseases |
| CN114207134B (zh) * | 2019-03-25 | 2024-11-15 | 俄亥俄州国家创新基金会 | 工程化的mRNA序列及其用途 |
| CN114450411A (zh) * | 2019-04-01 | 2022-05-06 | 特纳亚治疗股份有限公司 | 具有工程化衣壳的腺相关病毒 |
| AU2020310201A1 (en) * | 2019-07-10 | 2022-01-27 | Locanabio, Inc. | RNA-targeting knockdown and replacement compositions and methods for use |
| WO2021154923A2 (en) * | 2020-01-29 | 2021-08-05 | Voyager Therapeutics, Inc. | Methods and systems for producing aav particles |
| WO2021163357A2 (en) * | 2020-02-13 | 2021-08-19 | Tenaya Therapeutics, Inc. | Gene therapy vectors for treating heart disease |
| KR20240118855A (ko) * | 2021-12-10 | 2024-08-05 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 바이러스 벡터로 bag-3 관련 심근병증을 치료하는 방법 및 조성물 |
-
2023
- 2023-03-18 CA CA3254775A patent/CA3254775A1/en active Pending
- 2023-03-18 US US18/847,734 patent/US20250195694A1/en active Pending
- 2023-03-18 AU AU2023234604A patent/AU2023234604A1/en active Pending
- 2023-03-18 IL IL315697A patent/IL315697A/en unknown
- 2023-03-18 JP JP2024555341A patent/JP2025509828A/ja active Pending
- 2023-03-18 KR KR1020247034272A patent/KR20250007509A/ko active Pending
- 2023-03-18 EP EP23771729.3A patent/EP4493702A4/en active Pending
- 2023-03-18 WO PCT/US2023/064673 patent/WO2023178339A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| AU2017250791A1 (en) | Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy | |
| JP6573991B2 (ja) | 血管性浮腫の治療としてのｃ１ｅｉのアデノ随伴ウイルス介在性送達 | |
| JPWO2022053630A5 (https=) | ||
| CN114276419B (zh) | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 | |
| US11077208B2 (en) | Wilson's disease gene therapy | |
| CN113121651B (zh) | 低中和抗体腺相关病毒衣壳蛋白 | |
| JPWO2023178339A5 (https=) | ||
| CA3178591A1 (en) | Immunosuppressive agents and viral delivery re-dosing methods for gene therapy | |
| WO2023165477A1 (zh) | 白介素1受体拮抗蛋白的表达盒以及基于aav的基因递送系统 | |
| CN113121654B (zh) | 腺相关病毒衣壳蛋白及包含其的腺相关病毒载体 | |
| US12415850B2 (en) | Compositions and methods for regulating production of an antibody like protein and ribonucleic acid | |
| WO2021169167A1 (en) | Method for treating coronavirus infections | |
| JPWO2022031756A5 (https=) | ||
| JPWO2023108159A5 (https=) | ||
| JPWO2023108157A5 (https=) | ||
| WO2023124741A1 (zh) | 用于治疗肌营养不良症的转基因表达盒 | |
| CN121759520A (zh) | 一种lamp2b的过表达载体及其应用 | |
| CN109306011B (zh) | 靶向RyR2蛋白的胞内纳米抗体在制备抗心力衰竭药物中的用途 | |
| JP2022514271A5 (https=) | ||
| CN112961220A (zh) | 新型腺相关病毒衣壳蛋白及包含其的新型腺相关病毒载体 | |
| WO2026046394A1 (en) | Nucleic acids and uses thereof for plakophilin 2 (pkp2) gene therapy | |
| JPWO2020038473A5 (https=) | ||
| RU2021105703A (ru) | Кодон-оптимизированная нуклеиновая кислота, которая кодирует белок фактора свёртывания крови IX, и ее применение | |
| JPWO2023108029A5 (https=) |